This compound is a pharmaceutical intermediate used in the synthesis of nucleoside analogs. It is a tosylated derivative of deoxyadenosine, characterized by a purine base attached to a modified sugar ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5'-Tosyladenosine
research compound
2'-Deoxy-2'-fluoroguanosine
pharmaceutical intermediate
6H-Purin-6-one, 2-amino-9-[2,5-anhydro-4-C-(hydroxymethyl)-α-L-lyxofuranosyl]-1,9-dihydro-
pharmaceutical intermediate
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate
5-(hydroxymethyl)-2-furaldehyde
pharmaceutical intermediate
Barbituric acid
pharmaceutical intermediate
1-methyl-2-pyrrolidineethanol
pharmaceutical intermediate
5-Amino-6-methylbenzimidazolone
pharmaceutical intermediate
[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl 4-methylbenzenesulfonate
JBDNXJYWAILXSS-BFHYXJOUSA-N
CC1=CC=C(C=C1)S(=O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N3C=NC4=C(N=CN=C43)N)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.